In the studies on a series of pyridopyrimidine derivatives, one of the derivatives, piromidic acid (5), was found to be active against gramnegative bacteria and staphylococci and has been used for the treatment of intestinal, urinary, and biliary tract infections in man. Further studies on this series led to the discovery of another derivative named pipemidic acid (3) . This derivative has similar inherent chemotherapeutic properties to piromidic acid and nalidixic acid (1) but in addition has some properties different from the latter two drugs, i.e., in vitro and in vivo activity against Pseudomonas aeruginosa and against bacteria resistant to piromidic acid and nalidixic acid (unpublished data), good distribution to organs and tissues (6) , and stability to metabolic inactivation (6) . The present report describes the in vitro properties of pipemidic acid including a comparative study with piromidic acid and nalidixic acid. MATERIALS AND METHODS Drugs. Pipemidic acid (Fig. 1 ) was synthesized in this laboratory (3) . It usually contains 3 mol of water per molecule, whereas its potency is always expressed as anhydrous pipemidic acid. Piromidic acid and nalidixic acid were prepared as described previously (5) . Equimolar NaOH was added for the dissolution of these three acids in water. Cephalexin and gentamicin sulfate were purchased from Shionogi Co., Ltd., sodium ampicillin from Meiji Seika Kaisha Ltd., sodium carbenicillin from Fujisawa Pharmaceutical Co., Ltd., tetracycline hydrochloride from Takeda Chemical Industries, Ltd., chloramphenicol from Sankyo Co., Ltd., and streptomycin sulfate from Dainippon Pharmaceutical Co., Ltd.
Organisms Table 3 shows the distribution of the MICs of pipemidic acid and nalidixic acid for 635 clinical strains recently isolated in 31 hospitals in Japan. Seventy-eight to 100% of strains of E. coli, Proteus mirabilis, P. morganii, P. inconstans, Shigella sonnei, S. flexneri, Salmonella, Alcaligenes, and Vibrio parahaemolyticus were inhibited by pipemidic acid, and 67 to 100% were inhibited by nalidixic acid at 6.25 jsg/ml or lower. For two strains of Enterobacter, the MICs of pipemidic acid were 6.25 ,ug/ml, and those of nalidixic acid were 12.5 and 25 ,ug/ml.
Sixty to 100% of strains of S. aureus, S. epidermidis, P. rettgeri, P. vulgaris, Klebsiella pneumoniae, and Citrobacter were inhibited by pipemidic acid, and 11 to 67% were inhibited by nalidixic acid at 50,ug/ml or lower. In pseudomonads, most of which were resistant to 100 ug of nalidixic acid per ml, 71% were inhibited by 25 ,ug of pipemidic acid per ml and 90% were inhibited by 50 ,g per ml. Most enterococci and Serratia strains were inhibited by pipemidic acid in a concentration range of 100 to 400 Ag/ml, whereas they were resistant to nalidixic acid even at 400 ,ug/ml. It is evident from these results that most clinical strains are generally more susceptible to pipemidic acid than to nalidixic acid, and some strains practically resistant to nalidixic acid are also inhibited by pipemidic acid.
Susceptibility of pseudomonads to pipemidic acid was compared with that of carbenicillin and gentamicin using 100 fresh clinical isolates sent from the Central Research Laboratory, Faculty of Medicine, Kyushu University, and the Department of Pediatrics, Faculty of Medicine, Kurume University. Ninety-nine percent of the strains were inhibited by pipemidic acid at concentrations ranging 12.5 to 50 Ag/ml, which were generally lower than those of carbenicillin and higher than those of gentamicin (Fig. 2) . It was observed that these strains were Bactericidal activity. The growth curves of S. aureus Terajima, E. coli K-12, and P. aeruginosa Tsuchijima were made in the presence or absence of pipemidic acid (Fig. 3) . The multiplication of these organisms was inhibited by pipemidic acid at 12.5, 0.78, and 6.25 gg/ml, respectively, at least for a limited period of 6 h, and bactericidal activity was observed at 25, 1.56, and 6.25 lAg of the drug per ml.
DISCUSSION
Pipemidic acid is a new synthetic antibacterial drug structurally related to piromidic acid (5) and nalidixic acid (2). It has been known that piromidic acid and nalidixic acid are primarily active against gram-negative bacteria (1) and only the former is, in addition, active against staphylococci (5 
